Abstract
Many structural modifications have been made on the naturally occurring nucleosides in the search for medicinal agents that will interfere with the utilization of the natural compounds. One such area of pursuit has been the replacement of the oxygen of the ribofuranose ring of common nucleosides with a methylene unit (resulting in a cyclopentyl ring) leading to biologically meaningful carbanucleosides (carbocyclic nucleosides). This review calls attention to new methods for preparing these compounds in enantiomeric forms with various heterocyclic bases and ring contracted and expanded cyclopentyl substituents.
Keywords: carbocyclic nucleosides, structural modifications, expanded cyclopentyl substituents, synthetic considerations, bicycliclactam, cyclopentyl ring
Current Topics in Medicinal Chemistry
Title: Carbocyclic Nucleosides (Carbanucleosides) as New Therapeutic Leads
Volume: 2 Issue: 10
Author(s): Stewart W. Schneller
Affiliation:
Keywords: carbocyclic nucleosides, structural modifications, expanded cyclopentyl substituents, synthetic considerations, bicycliclactam, cyclopentyl ring
Abstract: Many structural modifications have been made on the naturally occurring nucleosides in the search for medicinal agents that will interfere with the utilization of the natural compounds. One such area of pursuit has been the replacement of the oxygen of the ribofuranose ring of common nucleosides with a methylene unit (resulting in a cyclopentyl ring) leading to biologically meaningful carbanucleosides (carbocyclic nucleosides). This review calls attention to new methods for preparing these compounds in enantiomeric forms with various heterocyclic bases and ring contracted and expanded cyclopentyl substituents.
Export Options
About this article
Cite this article as:
Schneller W. Stewart, Carbocyclic Nucleosides (Carbanucleosides) as New Therapeutic Leads, Current Topics in Medicinal Chemistry 2002; 2 (10) . https://dx.doi.org/10.2174/1568026023393228
DOI https://dx.doi.org/10.2174/1568026023393228 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
TNF-Related Apoptosis-Inducing Ligand (TRAIL) as a Pro-Apoptotic Signal Transducer with Cancer Therapeutic Potential
Current Pharmaceutical Design Endothelial Lipase: A Key Player in HDL Metabolism Modulates Inflammation and Atherosclerotic Risk
Mini-Reviews in Medicinal Chemistry Comparative Study of LC/MS and EMIT in Therapeutic Monitoring of Carbamazepine and its Clinical Applications
Current Pharmaceutical Analysis Targeted Elimination of Leukemia Stem Cells; a New Therapeutic Approach in Hemato-Oncology
Current Drug Targets Aldosteronism in Heart Failure: A Proinflammatory / Fibrogenic Cardiac Phenotype. Search for Biomarkers and Potential Drug Targets
Current Drug Targets Emerging Pharmacological Treatments to Prevent Abdominal Aortic Aneurysm Growth and Rupture
Current Pharmaceutical Design Astroglial Connexins as a Therapeutic Target for Alzheimer's Disease
Current Pharmaceutical Design Editorial (Thematic Issue: Strategies to Defeat HIV)
Current HIV Research Antiplatelet Agents in Cardiology: A Report on Aspirin, Clopidogrel, Prasugrel, and Ticagrelor
Current Pharmaceutical Design Guide of Hypertensive Crisis Pharmacotherapy
Cardiovascular & Hematological Disorders-Drug Targets Cyclophilin function in Cancer; lessons from virus replication
Current Molecular Pharmacology Plasticity of Neuroendocrine-Immune Interactions During Ontogeny: Role of Perinatal Programming in Pathogenesis of Inflammation and Stress- Related Diseases in Adults
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Recent Advances in the Treatment of Multiple Myeloma
Current Pharmaceutical Biotechnology Characterization of the Early CNS Stress Biomarkers and Profiles Associated with Neuropsychiatric Diseases
Current Genomics Editorial: [Hot Topic: Keeping Track of an Expanding Subject - Recent Trends in Immunology and their Clinical Implications]
Current Pharmaceutical Design Leptin and Vascular Smooth Muscle
Current Vascular Pharmacology A Local, Bottom-Up Perspective on Sleep Deprivation and Neurobehavioral Performance
Current Topics in Medicinal Chemistry The Nature of Immunological Reaction in the Peripheral Airways of Cigarette Smokers
Current Respiratory Medicine Reviews Design and Synthesis of 2-(Arylmethylideneamino) Isoindolines as New Potential Analgesic and Anti-Inflammatory Agents: A Molecular Hybridization Approach
Current Pharmaceutical Design <sup>1</sup>H and <sup>13</sup>C NMR Spectral Data of Neolignans Isolated from <i>Piper</i> Species
Current Organic Chemistry